.
 

linemiddle.gif (145 bytes)

Issuing company Apollonion Private Hospital Ltd
Nominal value per share 25 cents
Authorised share capital CYP 20.000.000 divided to 80.000.000 shares at a nominal value of 25 cents per share
Issued share capital before the present issue 12.373.339 Ordinary shares of nominal value of 25 cents per share
Issue of new shares The total number of shares that is offered for issue is 510.000 Ordinary shares of nominal value of 25 cents each at the price of 40 cents per share.
1.288.223 warrants will be offered at a ration of one Warrant for every 10 Ordinary shares that have been issued and subscribed or to the new Ordinary shares that are going to be issued and Subscribed until the date of the entrance of the Company to CSE.
Issued price of the new shares to the public 40 cents per share
Total number of shares after the present issue and entrance of the shares in to CSE 12.883.339 shares of nominal value of 25 cents per share.
Share Option Scheme With the entrance of the company's Ordinary Shares to CSE, the Share Option Scheme will be applied for the personnel and doctors-partners. More information is found on paragraph 13 of the company's prospectus.
Authorized Investment The company has applied for including its Ordinary Shares in the catalogue of the authorized investment according to Article 20 of the Insurance Company Laws of 1984 and 1990, of which it is expected to be approved with its entrance of its titles in CSE.
Scope of the new issues The net capital which will be raised from the present issue, will be used for the reinforcement of the working capital of the company, its organic growth, as well as its extension of its works.

 

linemiddle.gif (145 bytes)

Scope of the new issues

  • Expansion of the existing buildings
  • Purchase of land for future expansion in building.
  • Purchase of contemporary medical equipment.

linemiddle.gif (145 bytes)

GOALS

Short-term / Medium - term Goals

  • Development in other areas of medical services.
  • Cooperation with doctors and other private hospitals
  • Expansion in new areas of medical fields.
  • Entering CSE
  • Expansion of building to house more doctors.

Long - Term Goals

  • Establishment of the leading role of Apollonion hospital in the area of medical services provision.
  • Cooperation with medical centres of other countries.

linemiddle.gif (145 bytes)

SUMMARISED ECONOMIC ASPECTS

Evaluation of Apollonion hospital Price-Pounds
Adjusted profits after tax for the year 2001 270.562
Ration price to adjusted profit for the year 2001 14,06
Estimated value of the company (adjusted net profit for the year 2001 X price per earning ration) 3.804.935

Weighted average number of shares

9.512.339
Issued price (cents)* 40 cent
Adjusted profit  per share 2,84 cent

Based on the profit for the year 2001 that come up to 66.618 as shown to part 7.1 of the present information report/the rations price per earning for the year 2001 is 57.20 times.

The Group believes that the unusual expenses mentioned before will not be repeated neither to the near nor the long term future. The ratios: Issued price / Earning per share is considered by the Board of Directors to be calculated on the base of the adjusted profit as exactly presented to the above table, which is also analyzed in part 7.2
The earning per share ration for the year 2001 after the adjustments, is estimated to 2.84 cents, whereas the ration price profit in the issued price of the share has been estimated to be 14.06 times. The ratio issued price / accountance price of the share on 31 December 2001 comes up to 1,32 times.
The ration price per earnings which is used for the calculation of the value of the company is within the respected ration price profit that were used in recent entries of companies to CSE.

 
PROFIT AND LOSS ACCOUNT FOR THE YEAR 2001 Audited Financial Accounts For The year 2001 2001 Adjusted Account Results For The Information Report For Registration
Revenue 2.126.279 2.126.279
Administration expenses (1.611.028) (1.611.028)
Operation profit from normal activities 515.251 515.251
Financing Expenses (142.704) (86.495)
Amortization of goodwill (10.921) (10.921)
Share of profits/Loss from Associate companies (77.037) (0)
Amortization of negative Goodwill - -
Profit of the year before tax 284.589 417.835
Tax (218.071) (147.273)
Profit of the year after tax 66.518 270.562